Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × Tacrolimus × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 14 Myelodysplastic Syndromes 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Hematologic Neoplasms 5 Primary Myelofibrosis 4 Myeloproliferative Disorders 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Anemia, Refractory, with Excess of Blasts 4 Lymphoproliferative Disorders 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Lymphoid 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Biphenotypic, Acute 3 Leukemia 3 Hematologic Diseases 3 Preleukemia 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Mantle-Cell 2 Lymphatic Diseases 2 Leukemia, Myeloid 2 Leukemia, B-Cell 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hodgkin Disease 2 Graft vs Host Disease 2

Interventions

Dexamethasone 15 Cyclophosphamide 12 pembrolizumab 11 Rituximab 11 venetoclax 10 pomalidomide 10 fludarabine 9 Lenalidomide 8 Calcium Dobesilate 7 glofitamab 6 Gemcitabine 6 Cytarabine 6 carfilzomib 5 Temozolomide 5 Nivolumab 5 Etoposide 5 Bevacizumab 5 selinexor 4 ruxolitinib 4 obinutuzumab 4 daratumumab 4 Doxorubicin 4 Carboplatin 4 Capecitabine 4 Bortezomib 4 Azacitidine 4 zanubrutinib 3 tisagenlecleucel 3 elotuzumab 3 blinatumomab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡